Researchers from Kyorin University Describe Findings in Central Nervous System Disorders (Phase 1/2 Study of Tirabrutinib, a Second-Generation Bruton's Tyrosine Kinase Inhibitor, in Relapsed/Refractory Primary Central Nervous System Lymphoma)

Source :: Obesity, Fitness & Wellness Week. July 11, 2020, 1785
Publication Year :: 2020
Abstract: 2020 JUL 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Neurology - Central Nervous System Disorders is the subject [...]

Subjects :: Physical fitness -- Research -- Reports
Tyrosine -- Research -- Reports
Medical research -- Reports
Nervous system diseases -- Research
Central nervous system -- Reports -- Research
Lymphomas -- Research
Phenols (Class of compounds) -- Research -- Reports
Health

Tools